SCHEMBL21995608

SCHEMBL21995608

Oc1ccc(Cl)cc1-c1cccc(Br)c1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHX2 P34913 1/20 0.41
▸ MEN1 O00255 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ MAPT P10636 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ RXFP1 Q9HBX9 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ PIM1 P11309 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ IDO1 P14902 4/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38
▸ P2RX1 P51575 1/20 0.38
▸ CYP19A1 P11511 1/20 0.38
▸ MGAM O43451 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21755999 0.88 CXCR2 (0.44) MEN1HPGDKMT2AMAPTLMNA
SCHEMBL19802353 0.79 EPHX2 (0.41) EPHX2MEN1HPGDKMT2AMAPT
SCHEMBL20739878 0.79 AMY1A (0.42) MEN1KMT2AMAPTALDH1A1HSD17B10
SCHEMBL30604354 0.78 ALDH1A1 (0.41) MEN1HPGDKMT2AMAPTLMNA
SCHEMBL22195968 0.76 ALDH1A1 (0.43) MEN1HPGDKMT2AMAPTALDH1A1
SCHEMBL25916103 0.76 ALDH1A1 (0.33) MEN1HPGDKMT2AALDH1A1SMN1; SMN2
SCHEMBL31093991 0.75 HSD17B10 (0.62) EPHX2MEN1HPGDKMT2AMAPT
SCHEMBL6242615 0.75 HSD17B10 (0.62) EPHX2MEN1HPGDKMT2AMAPT
SCHEMBL5927386 0.75 KCNMA1 (0.46) EPHX2MEN1HPGDKMT2AMAPT
SCHEMBL21926786 0.75 NPC1 (0.39) HPGDALDH1A1SMN1; SMN2TSHRHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301183-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-09-21 — — US disclosed
US-20230301183-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-09-21 — — US disclosed
WO-2020141949-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2020-07-09 — — WO disclosed
WO-2020111663-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 두산솔루스 주식회사 2020-06-04 — — WO disclosed
WO-2020111663-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME 두산솔루스 주식회사 2020-06-04 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301183-A1 ORGANIC LIGHT EMITTING DEVICE CRY1, CRY2, CYP1A1 EPHX2 272/4885MEN1 929/4885HPGD 2230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback